DIP Ep 596: 2025 USMLE Step 1 Free 120 Discussion Part 11b (Q106-110, super helpful for Step 2 and 3!)

DIP Ep 596: 2025 USMLE Step 1 Free 120 Discus...

Up next

DIP Ep 630: 2 High Yield Integrated Cases (Step 1-3)

In this podcast, I discuss 2 cases that encapsulate a large number of concepts frequently tested on the USMLE exams. I discuss a host of arrows, make necessary integrations, and help you understand pathophysiology every step of the way. You will almost certainly see some antecede ...  Show more

25 Hour Step 1 Basic Science Review (Starts Feb 2, 2026)

In this short podcast, I discuss the upcoming 25 Hour USMLE Step 1 Basic Science Review starting at 5.45 pm EST each day from 2/2-7, 2026 over zoom. The review will be incredibly clinical, focus on integrations, help you understand pathophysiology, and expose you to a large amoun ...  Show more

Recommended Episodes

Episode 006: Heme Path Capstone Pt. 1
The Fellow on Call: The Heme/Onc Podcast

Heme Path Capstone Pt. 1 Pearls

It’s time to put all you have learned in our Heme Path series to the test! Listen in as our guest, Dr. Emily Mason, hematopathologist at Vanderbilt University Me ...

  Show more

Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ...

  Show more

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
The Fellow on Call: The Heme/Onc Podcast

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...

  Show more

Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ...

  Show more